HSCS: HeartSciences Inc. Company Profile & Statistics

About

Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.

Info & Links

CEO

Andrew Simpson

Headquarters

550 RESERVE ST, SUITE 360
SOUTHLAKE, TX 76092, UNITED STATES

Auditor

Haskell & White LLP

Share holders

292

Employees

HeartSciences Inc. Statistics

Valuation Measures

Market Capitalization²

3.44M

Enterprise Value

-400.00K

Enterprise Value/EBITDA(ttm)

0.06

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.54

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

32.50%

Operating Margin(ttm)

Profit Margin(ttm)

-14003.15%

Return on Equity(ttm)

-144.12%

Return on Invested Capital(ttm)

29.82%

Return on Assets(ttm)

-94.48%

Income Statement

Revenue(ttm)

18.60K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

12.50K

EBITDA(ttm)³

-6.85M

Net Income Available to Common(ttm)

-7.29M

Diluted EPS(ttm)

-21.64

Share Statistics

Beta (5Y Monthly)

3.23

52-Week Change

-80.05%

S&P 500 52-Week Change

25.95%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

911.32K

Dividend Yield

0.00%

Float⁴

897.00K

% Held by Insiders

1.80%

% Held by Institutions

17.24%

Balance Sheet

Total Cash(mrq)

4.34M

Total Cash Per Share(mrq)

4.76

Total Debt(mrq)

500.00K

Total Debt/Equity(mrq)

8.43%

Current Ratio(mrq)

4.49%

Quick Ratio(mrq)

4.02%

Book Value Per Share(mrq)

6.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.60

Free Cash Flow(ytd)

-2.02M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HSCS

HeartSciences Inc.

HeartSciences Inc. Profile